Page 1 | Search Results | Blood Advances | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study

Tania Jain, Noel Estrada-Merly, M. Queralt Salas, Soyoung Kim, Jakob DeVos, Min Chen, Xi Fang, Rajat Kumar, Marcio Andrade-Campos, Hany Elmariah, Vaibhav Agrawal, Mahmoud Aljurf, Ulrike Bacher, Talha Badar, Sherif M. Badawy, Karen Ballen, Amer Beitinjaneh, Vijaya Raj Bhatt, Christopher Bredeson, Zachariah DeFilipp, Bhagirathbhai Dholaria, Nosha Farhadfar, Shatha Farhan, Arpita P. Gandhi, Siddhartha Ganguly, Usama Gergis, Michael R. Grunwald, Nada Hamad, Betty K. Hamilton, Yoshihiro Inamoto, Madiha Iqbal, Omer Jamy, Mark Juckett, Mohamed A. Kharfan-Dabaja, Maxwell M. Krem, Deepesh P. Lad, Jane Liesveld, Monzr M. Al Malki, Adriana K. Malone, Hemant S. Murthy, Guillermo Ortí, Sagar S. Patel, Attaphol Pawarode, Miguel-Angel Perales, Marjolein van der Poel, Olle Ringden, David A. Rizzieri, Alicia Rovó, Bipin N. Savani, Mary Lynn Savoie, Sachiko Seo, Melhem Solh, Celalettin Ustun, Leo F. Verdonck, John R. Wingard, Baldeep Wirk, Nelli Bejanyan, Richard J. Jones, Taiga Nishihori, Betul Oran, Ryotaro Nakamura, Bart Scott, Wael Saber, Vikas Gupta

Blood Adv (2024) 8 (16): 4281–4293.

https://doi.org/10.1182/bloodadvances.2024013451

Published: 2024

Includes: Supplemental data

Journal Articles

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis

Hemant S. Murthy, Mei-Jie Zhang, Karen Chen, Sairah Ahmed, Uday Deotare, Siddhartha Ganguly, Ankit Kansagra, Fotios V. Michelis, Taiga Nishihori, Mrinal Patnaik, Muhammad Bilal Abid, Mahmoud Aljurf, Yasuyuki Arai, Ulrike Bacher, Talha Badar, Sherif M. Badawy, Karen Ballen, Minoo Battiwalla, Amer Beitinjaneh, Nelli Bejanyan, Vijaya Raj Bhatt, Valerie I. Brown, Rodrigo Martino, Jean-Yves Cahn, Paul Castillo, Jan Cerny, Saurabh Chhabra, Edward Copelan, Andrew Daly, Bhagirathbhai Dholaria, Miguel Angel Diaz Perez, César O. Freytes, Michael R. Grunwald, Shahrukh Hashmi, Gerhard C. Hildebrandt, Omer Jamy, Jacinth Joseph, Christopher G. Kanakry, Nandita Khera, Maxwell M. Krem, Yachiyo Kuwatsuka, Hillard M. Lazarus, Lazaros J. Lekakis, Hongtao Liu, Dipenkumar Modi, Pashna N. Munshi, Alberto Mussetti, Neil Palmisiano, Sagar S. Patel, David A. Rizzieri, Sachiko Seo, Mithun Vinod Shah, Akshay Sharma, Melhm Sohl, Scott R. Solomon, Matthew Ulrickson, Celalettin Ustun, Marjolein van der Poel, Leo F. Verdonck, John L. Wagner, Trent Wang, Baldeep Wirk, Amer Zeidan, Mark Litzow, Partow Kebriaei, Christopher S. Hourigan, Daniel J. Weisdorf, Wael Saber, Mohamed A. Kharfan-Dabaja

Blood Adv (2023) 7 (22): 7007–7016.

https://doi.org/10.1182/bloodadvances.2023011308

Published: 2023

Includes: Supplemental data

Journal Articles

Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma

Blood Adv (2022) 6 (24): 6109–6119.

https://doi.org/10.1182/bloodadvances.2022008320

Published: 2022

Includes: Supplemental data

Journal Articles

Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A -rearranged AML

Kamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, Mei-Jie Zhang, Khalid Bo-Subait, Jonathan Sanchez, Hai-Lin Wang, Mahmoud Aljurf, Amer Assal, Vera Ulrike Bacher, Sherif M. Badawy, Nelli Bejanyan, Vijaya Raj Bhatt, Christopher Bredeson, Michael Byrne, Paul Castillo, Jan Cerny, Saurabh Chhabra, Stefan Octavian Ciurea, Zachariah DeFilipp, Nosha Farhadfar, Shahinaz Gadalla, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael R. Grunwald, Shahrukh Hashmi, Gerhard Hildebrandt, Christopher G. Kanakry, Ankit Kansagra, Farhad Khimani, Maxwell Krem, Hillard Lazarus, Hongtao Liu, Rodrigo Martino, Fotios V. Michelis, Sunita Nathan, Taiga Nishihori, Richard Olsson, Ran Reshef, David Rizzieri, Jacob M. Rowe, Bipin N. Savani, Sachiko Seo, Akshay Sharma, Melhem Solh, Celalettin Ustun, Leo F. Verdonck, Christopher Hourigan, Brenda Sandmaier, Mark Litzow, Partow Kebriaei, Daniel Weisdorf, Yanming Zhang, Martin S. Tallman, Wael Saber

Blood Adv (2022) 6 (3): 828–847.

https://doi.org/10.1182/bloodadvances.2021004881

Published: 2022

Includes: Supplemental data

Journal Articles

A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease

Blood Adv (2022) 6 (1): 259–269.

https://doi.org/10.1182/bloodadvances.2021005552

Published: 2022

Includes: Supplemental data

Journal Articles

A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation

Blood Adv (2021) 5 (5): 1154–1163.

https://doi.org/10.1182/bloodadvances.2020003779

Published: 2021

Journal Articles

Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation

Blood Adv (2020) 4 (9): 2073–2083.

https://doi.org/10.1182/bloodadvances.2020001499

Published: 2020

Includes: Supplemental data

Journal Articles

Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia

Blood Adv (2019) 3 (20): 3123–3131.

https://doi.org/10.1182/bloodadvances.2019000722

Published: 2019

Includes: Supplemental data

Journal Articles

Myeloablative vs reduced intensity T-cell–replete haploidentical transplantation for hematologic malignancy

Blood Adv (2019) 3 (19): 2836–2844.

https://doi.org/10.1182/bloodadvances.2019000627

Published: 2019

Journal Articles

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission

Armin Rashidi, Mehdi Hamadani, Mei-Jie Zhang, Hai-Lin Wang, Hisham Abdel-Azim, Mahmoud Aljurf, Amer Assal, Ashish Bajel, Asad Bashey, Minoo Battiwalla, Amer M. Beitinjaneh, Nelli Bejanyan, Vijaya Raj Bhatt, Javier Bolaños-Meade, Michael Byrne, Jean-Yves Cahn, Mitchell Cairo, Stefan Ciurea, Edward Copelan, Corey Cutler, Andrew Daly, Miguel-Angel Diaz, Nosha Farhadfar, Robert P. Gale, Siddhartha Ganguly, Michael R. Grunwald, Theresa Hahn, Shahrukh Hashmi, Gerhard C. Hildebrandt, H. Kent Holland, Nasheed Hossain, Christopher G. Kanakry, Mohamed A. Kharfan-Dabaja, Nandita Khera, Yener Koc, Hillard M. Lazarus, Jong-Wook Lee, Johan Maertens, Rodrigo Martino, Joseph McGuirk, Reinhold Munker, Hemant S. Murthy, Ryotaro Nakamura, Sunita Nathan, Taiga Nishihori, Neil Palmisiano, Sagar Patel, Joseph Pidala, Rebecca Olin, Richard F. Olsson, Betul Oran, Olov Ringden, David Rizzieri, Jacob Rowe, Mary Lynn Savoie, Kirk R. Schultz, Sachiko Seo, Brian C. Shaffer, Anurag Singh, Melhem Solh, Keith Stockerl-Goldstein, Leo F. Verdonck, John Wagner, Edmund K. Waller, Marcos De Lima, Brenda M. Sandmaier, Mark Litzow, Dan Weisdorf, Rizwan Romee, Wael Saber

Blood Adv (2019) 3 (12): 1826–1836.

https://doi.org/10.1182/bloodadvances.2019000050

Published: 2019

Includes: Supplemental data

Journal Articles

Predictive value of disease risk comorbidity index for overall survival after allogeneic hematopoietic transplantation

Nelli Bejanyan, Claudio G. Brunstein, Qing Cao, Aleksandr Lazaryan, Celalettin Ustun, Erica D. Warlick, Mukta Arora, John E. Wagner, Daniel J. Weisdorf

Blood Adv (2019) 3 (3): 230–236.

https://doi.org/10.1182/bloodadvances.2018018549

Published: 2019

Journal Articles

Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis

Blood Adv (2018) 2 (8): 933–940.

https://doi.org/10.1182/bloodadvances.2018018531

Published: 2018

Includes: Supplemental data

Journal Articles

Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD

Nelli Bejanyan, Claudio G. Brunstein, Qing Cao, Aleksandr Lazaryan, Xianghua Luo, Julie Curtsinger, Rohtesh S. Mehta, Erica Warlick, Sarah A. Cooley, Bruce R. Blazar, Jeffrey S. Miller, Daniel Weisdorf, John E. Wagner, Michael R. Verneris

Blood Adv (2018) 2 (8): 909–922.

https://doi.org/10.1182/bloodadvances.2017014464

Published: 2018

Includes: Supplemental data

NARROW

Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis

Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma

Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A -rearranged AML

A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease

A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation

Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation

Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia

Myeloablative vs reduced intensity T-cell–replete haploidentical transplantation for hematologic malignancy

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission

Predictive value of disease risk comorbidity index for overall survival after allogeneic hematopoietic transplantation

Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis

Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only